146 related articles for article (PubMed ID: 25053929)
1. Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung Injury.
Jimenez-Marco T; Ruiz-Alderton D; Bautista-Gili AM; Girona-Llobera E
Transfus Med Hemother; 2014 Jun; 41(3):172-5. PubMed ID: 25053929
[TBL] [Abstract][Full Text] [Related]
2. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
Smith J; Rock G
Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma evaluated with INR-quantification.
Stanojkovic Z; Balint B; Antic A; Todorovic M; Ostojic G; Pavlovic M
Transfus Apher Sci; 2012 Aug; 47(1):33-7. PubMed ID: 22465578
[TBL] [Abstract][Full Text] [Related]
4. TRALI following fresh frozen plasma resuscitation from burn shock.
Jones LM; Deluga N; Bhatti P; Scrape SR; Bailey JK; Coffey RA
Burns; 2017 Mar; 43(2):397-402. PubMed ID: 28029475
[TBL] [Abstract][Full Text] [Related]
5. Incidence of transfusion-related acute lung injury temporally associated with solvent/detergent plasma use in the ICU: A retrospective before and after implementation study.
Klanderman RB; van Mourik N; Eggermont D; Peters AL; Tuinman PR; Bosman R; Endeman H; Cremer OL; Arbous SM; Vlaar APJ
Transfusion; 2022 Sep; 62(9):1752-1762. PubMed ID: 35919958
[TBL] [Abstract][Full Text] [Related]
6. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
7. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R
Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
[TBL] [Abstract][Full Text] [Related]
8. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.
Chapman CE; Stainsby D; Jones H; Love E; Massey E; Win N; Navarrete C; Lucas G; Soni N; Morgan C; Choo L; Cohen H; Williamson LM;
Transfusion; 2009 Mar; 49(3):440-52. PubMed ID: 18980623
[TBL] [Abstract][Full Text] [Related]
9. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study.
Nakazawa H; Ohnishi H; Okazaki H; Hashimoto S; Hotta H; Watanabe T; Ohkawa R; Yatomi Y; Nakajima K; Iwao Y; Takamoto S; Shimizu M; Iijima T
Transfusion; 2009 Nov; 49(11):2434-41. PubMed ID: 19624605
[TBL] [Abstract][Full Text] [Related]
10. Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.
Saadah NH; van Hout FMA; Schipperus MR; le Cessie S; Middelburg RA; Wiersum-Osselton JC; van der Bom JG
Transfusion; 2017 Sep; 57(9):2104-2114. PubMed ID: 28766723
[TBL] [Abstract][Full Text] [Related]
11. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
12. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
[TBL] [Abstract][Full Text] [Related]
13. Swiss Haemovigilance Data and Implementation of Measures for the Prevention of Transfusion Associated Acute Lung Injury (TRALI).
Jutzi M; Levy G; Taleghani BM
Transfus Med Hemother; 2008; 35(2):98-101. PubMed ID: 21512635
[TBL] [Abstract][Full Text] [Related]
14. Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components.
Silliman CC; Khan SY; Ball JB; Kelher MR; Marschner S
Vox Sang; 2010 May; 98(4):525-30. PubMed ID: 19951305
[TBL] [Abstract][Full Text] [Related]
15. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
[TBL] [Abstract][Full Text] [Related]
16. Real-time measurement of platelet shape change by light scattering under riboflavin and ultraviolet light treatment.
Terada C; Shiba M; Satake M; Tadokoro K
Transfusion; 2016 Mar; 56(3):587-95. PubMed ID: 26536611
[TBL] [Abstract][Full Text] [Related]
17. [Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: effects on plasma proteins and coagulation factor VII].
Stanojković Z; Antić A
Vojnosanit Pregl; 2011 Jan; 68(1):51-6. PubMed ID: 21425619
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results.
Renaudier P; Schlanger S; Vo Mai MP; Ounnoughene N; Breton P; Cheze S; Girard A; Hauser L; Legras JF; Odent-Malaure H; Rebibo D; Waller C; Willaert B; Caldani C;
Transfus Med Hemother; 2008; 35(2):89-91. PubMed ID: 21512633
[TBL] [Abstract][Full Text] [Related]
19. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
